Culmen International, LLC

Culmen International, LLC, headquartered in Alexandria, Virginia, is a for-profit limited liability company that delivers technical, international security, management, and logistics services to federal defense, diplomatic, and civilian agencies as a prime contractor on the vast majority of its awards (94% prime posture) and selectively as a subcontractor. The company competes predominantly in full-and-open procurements without set-aside designations, though it holds some Total Small Business set-aside positions on select delivery orders and IDIQs; it operates as a manufacturer of goods alongside its service delivery profile.

Culmen's capability portfolio spans language instruction across Arabic, Russian, Ukrainian, and English; naval medical research support and infectious disease surveillance; international security advisory services and border security capacity-building; equipment procurement and logistics for foreign military sales and nonproliferation initiatives; program management and administrative support; and operations and training services globally. Recent representative work includes a $15.4 million delivery order from the Defense Health Agency for infectious disease research and surveillance (awarded March 2025), a $12.5 million delivery order under Omnibus IV for medical readiness systems biology research support and drug development for diarrheal and bacterial diseases (awarded November 2024), and a $9.6 million delivery order from PEO Enterprise Information Systems for acquisition and engineering support services (awarded March 2025). Culmen also holds a $1.6 million delivery order from the Bureau of International Narcotics and Law Enforcement Affairs for non-intrusive inspection equipment for Mexican federal prisons (awarded June 2026) and a $38.4 million definitive contract from the Defense Threat Reduction Agency for transit, logistics, and interpretation support under the Cooperative Threat Reduction Program (awarded July 2024).

Customer concentration is dispersed across 71 agencies, though the top tier reflects operational focus. By award count, the Defense Security Cooperation Agency dominates with 104 awards ($34.3 million potential value), followed by the Department of State's Bureau of International Security and Nonproliferation (45 awards, $370.9 million), the Department of the Navy's Bureau of Medicine and Surgery (26 awards, $70.9 million), United States Special Operations Command (23 awards, $49.2 million), and the Office of the Secretary of Defense (20 awards, $38.5 million). By dollar value, the ranking shifts dramatically: the Department of the Navy's Naval Supply Systems Command anchors 14 awards carrying $75.83 billion in combined ceiling value, predominantly through the Maritime Acquisition Advancement Contract (MAAC), a $10 billion multiple-award IDIQ awarded May 2025. The Department of the Army's Joint PEO Chemical and Biological Defense follows with $1.91 billion across eight awards, and the Department of the Air Force's Air Combat Command contributes $1.08 billion across eleven awards. This bifurcated concentration—many small awards from DSCA and State ISN, but the largest dollar exposure through Navy and Army maritime and CBRN equipment vehicles—indicates customer diversity alongside selective deep penetration of high-value logistics and equipment procurement channels.

Vehicle position is extensive. Culmen holds or sits on twenty-plus IDIQs and BPAs spanning defense, diplomatic, and civilian agencies. Anchor vehicles include the Maritime Acquisition Advancement Contract ($10 billion ceiling, Navy, 14 task orders, $75.83 billion combined potential—a placeholder vehicle); the Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program ($151 billion ceiling, Missile Defense Agency, multiple-award, 10-year period through December 2035, awarded December 2025); the Transportation Security Administration Screening Partnership Program ($5.3 billion single-award IDIQ for airport screening services nationwide, awarded June 2026); GLOBALCAP ($5 billion multiple-award IDIQ, Bureau of African Affairs, training, equipment, logistics, and construction for sub-Saharan Africa through June 2035, awarded July 2025); the Worldwide Expeditionary Multiple Award Contract TITUS (WEXMAC TITUS) ($65.8 billion ceiling, Naval Supply Systems Command, awarded January 2025); the Department of Defense Counter Narcotics and Global Threats (CN&GT) contract ($960 million multiple-award IDIQ, Air Combat Command, through September 2032); the One Acquisition Solution for Integrated Services Plus (OASIS+ Unrestricted) ($999,999,999,999 placeholder ceiling, GSA, multiple-award, through December 2029, awarded December 2024); and the One Acquisition Solution for Integrated Services—Small Business (OASIS SB) small business set-aside vehicle. Culmen also holds a $100 million single-award IDC with the International Development Finance Corporation for international and domestic staffing services (through September 2028) and a $75 billion single-award HHS Influx Care Facility IDIQ for emergency shelter and support services (through February 2025, awarded March 2023). Additionally, Culmen maintains language instruction BPAs and single-award vehicles with the Defense Security Cooperation Agency—Russian, Ukrainian, and English language instruction vehicles with ceilings between $700,000 and $900,000 through October 2029—and the Department of State's International Security and Nonproliferation bureau, including a $90 million BPA for specialized operational equipment (thermal/night vision, unmanned systems, CBRNE detection equipment) through September 2025.

Activity trajectory shows acceleration. Awards per year grew from 17 in 2022 to 42 in 2023, held flat at 42 in 2024, then jumped to 60 in 2025; partial-year 2026 (through June) shows 11 awards. The combined potential value across all 463 prime and sub awards totals $174.62 billion, though only $686.7 million is obligated—a 0% obligated share indicating these are ceilings and orders are being drawn incrementally. A 24-month recompete cliff window captures 41 awards with completion dates in the next two years and combined potential value of $71.1 million; this is modest relative to total ceiling exposure, reflecting the long ordering periods embedded in the mega-vehicle portfolio.

SCI-reported invoicing on federal service contracts (a partial view excluding goods, products, and classified work) shows $51.1 million in prime-level invoiced revenue across FY2022–FY2024. FY2022 recorded $27.3 million across roughly 28.8 FTEs; FY2023 dropped to $20.2 million across 13.3 FTEs; FY2024 recovered to $3.7 million across 2.6 FTEs reported through mid-year capture. SCI FTE data for the full portfolio across FY2022–FY2024 shows 31.7 FTEs in FY2022, 12.3 in FY2023, and 35.9 in FY2024 (including sub engagement), suggesting volatile seasonal or contract-cycle staffing rather than steady growth. On federal services contracts captured in SCI, median government-paid rates ran around $172.92/hr, with the 10th percentile at $128.98/hr and the 90th percentile at $2,771.47/hr—the wide spread reflecting a portfolio spanning low-cost administrative staff, mid-tier technical labor, and specialized research and advisory expertise. Across SCI-reportable prime contracts, subcontractors represented an average of 2% of total contractor hours delivered, and only five named subcontractors are identified in the SCI dataset, indicating Culmen builds its own delivery teams and does not rely substantially on subs for federal service work.

Teaming pattern reflects hybrid positioning. As a prime contractor, Culmen executes the vast majority of its work directly, with minimal sub engagement on SCI-reportable service contracts (2% average sub-hours share). However, on the subcontractor side, Culmen appears as a named sub to major integrators and large primes: Booz Allen Hamilton (multiple program management and technical support orders for European theater operations, modernization analysis, and intelligence support), Caci NSS LLC (base contract award and option exercise), KBR Wyle Services (aircraft armament and fuel systems analysis), Family Health International (infectious disease detection strengthening in Uzbekistan), HII Mission Technologies Corp (joint network intelligence support), AECOM Services (staffing support), and notably Hunatek-Culmen JV LLC and Htgs-Culmen JV LLC (joint venture arrangements for Africa Center for Strategic Studies business processes, State Department facilities management, and DOE/NNSA global materials security technical support). The JV structure with Hunatek and HTGS indicates Culmen partners strategically on specific agency relationships or capability requirements rather than operating as a feeder subcontractor. At the prime level, Culmen's rare visible sub relationships include work alongside smaller specialized partners, but the overwhelming picture is direct delivery.

Federal grant activity is limited but strategically focused on international security and health. Culmen is a recipient on two active cooperative agreements: a $5.21 million award from the Bureau of Counterterrorism under Global Counterterrorism Programs (CFDA 19.701, September 2025 through September 2028) for community engagement, communication channels, and border security capacity-building in Libya; and an earlier cooperative agreement with the International Security and Nonproliferation bureau for the North African Border Security Management Academy (closed out February 2025). A third award, a $4.55 million cooperative agreement from the Bureau of Counterterrorism to enhance aviation security at Sebha International Airport in Libya (awarded September 2023, extended through September 2026), rounds out the federal grant footprint. These awards sit outside the prime contract portfolio and underscore Culmen's role as a capacity-building partner for U.S. foreign policy in Africa and the Middle East.

Corporate structure includes two named subsidiaries: Vysnova Partners, LLC and Analytic Strategies LLC, both for-profit limited liability companies. Vysnova appears in the source as a recipient of delivery orders under the Omnibus IV Military Medical Research and Development IDIQ for medical readiness systems biology, clinical research support, and implementation science services, suggesting Vysnova may carry specialized medical research and health-focused capabilities within the Culmen portfolio, though the source does not explicitly detail the subsidiary's role or degree of operational separation.

Culmen's competitive posture is non-set-aside dominant but selective. The vast majority of prime awards carry no set-aside designation, positioning the company to compete in full-and-open procurements across all federal agencies. However, scattered Total Small Business set-aside awards appear—including the Omnibus IV infectious disease and medical readiness orders, the Joint PEO CBRN defense vehicle ($500 million ceiling, August 2025), OASIS SB placement, clinical research support at Keesler AFB, and select Army weaponry and logistics orders. This selective set-aside presence suggests Culmen qualifies as small business by SBA standards, yet does not rely primarily on set-aside vehicles; the company's primary strength lies in competing and winning large, unrestricted IDIQ and delivery order vehicles where scale, past performance, and technical depth carry weight.

Program management, acquisition support, financial analysis, engineering, procurement, intl logistics, and language services for WMD Nonproliferation, Border Security, FMS, FMA, Intl Development, and Military, Intelligence & Law Enforcement Operations.